News

Corporate Compliance Insights18h
Exploring CorpFin’s New Perspective on Covered Stablecoins
The regulatory landscape for digital assets continues evolving as the SEC's Division of Corporation Finance stakes out new ...
The Manila Times18h
BioXcel Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
Net Loss: BioXcel Therapeutics had a net loss of $7.3 million for the first quarter of 2025, compared to a net loss of $26.8 ...